Bill Sponsor
House Bill 220
116th Congress(2019-2020)
National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019
Introduced
Introduced
Introduced in House on Jan 3, 2019
Overview
Text
Introduced
Jan 3, 2019
Latest Action
Jan 25, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
220
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
New Jersey
Democrat
California
Republican
Florida
Democrat
New Hampshire
Democrat
New Jersey
Democrat
New Jersey
Republican
New York
Democrat
New York
Democrat
New York
Republican
Pennsylvania
Republican
Pennsylvania
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

National Lyme and Tick-Borne Diseases Control and Accountability Act of 2019

This bill establishes the Office of Oversight and Coordination for Tick-Borne Diseases within the Department of Health and Human Services (HHS). The office must oversee the creation of a national strategy to address Lyme disease and other tick-borne diseases and disorders. The national strategy must include program assessments, benchmarks for progress, and recommendations from the previously established Tick-Borne Disease Working Group.

The bill also requires HHS to undertake specific actions that promote research, prevention, and treatment of Lyme disease and other tick-borne diseases and disorders. Among other things, HHS must:

  • support expansive research into the pathology, diagnosis, and treatment of such diseases and disorders;
  • establish a surveillance system to track the prevalence of such diseases and disorders in humans;
  • establish a surveillance system to track the prevalence of disease-carrying ticks;
  • conduct educational campaigns; and
  • hold a series of research symposiums.
Text (1)
January 3, 2019
Actions (3)
01/25/2019
Referred to the Subcommittee on Health.
01/03/2019
Referred to the House Committee on Energy and Commerce.
01/03/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 1:49:27 PM